國立虎尾科技大學 |

Mucosal Delivery of Drugs and Biologics in Nanoparticles

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Mucosal Delivery of Drugs and Biologics in Nanoparticles/ edited by Pavan Muttil, Nitesh K. Kunda.
其他作者:	Kunda, Nitesh K.
面頁冊數:	VIII, 277 p. 52 illus., 42 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Pharmaceutical Sciences/Technology. -
電子資源:	https://doi.org/10.1007/978-3-030-35910-2
ISBN:	9783030359102

Mucosal Delivery of Drugs and Biologics in Nanoparticles
Mucosal Delivery of Drugs and Biologics in Nanoparticles[electronic resource] /edited by Pavan Muttil, Nitesh K. Kunda. - 1st ed. 2020. - VIII, 277 p. 52 illus., 42 illus. in color.online resource. - AAPS Advances in the Pharmaceutical Sciences Series,412210-7371 ;. - AAPS Advances in the Pharmaceutical Sciences Series,20.

Section I Background -- Introduction to Nanomedicine -- Characterization of Nanoparticles -- Section II Drugs and Biologics Encapsulated in Nanoparticles -- Routes of Delivery -- Small molecule Delivery -- Peptide and Protein Delivery -- Gene Delivery (siRNA/CRISPR) -- Phage Therapy -- Section III Diseases -- Non-infectious Diseases -- Infectious Diseases -- Cancer -- Section IV Host Interactions with Nanoparticles -- Interaction of Nanoparticles with Epithelial and Immune Cells -- Toxicity of Nanoparticles to the Host -- Nanoparticle Pharmacokinetics and Pharmacodynamics -- Section V MIscellanous -- Nanoparticles as Theranostics -- Regulatory Perspectives -- Manufacturing Scale-up of Nanoparticles.

This book focuses on the application of nanotechnology to deliver drugs and biological agents by the mucosal routes of administration i.e. nasal, pulmonary, buccal, and oral routes.It provides an overview of nanotechnology in drug delivery with a description of different types of nanoparticles, methods of preparation and characterization, and functionalization for site-specific drug delivery. Mucosal Delivery of Drugs and Biologics in Nanoparticles emphasize the use of nanoparticles in treating various cancers and infectious diseases. It broadens the use of nanoparticles by including biologics, including vaccines and immunotherapies, apart from drugs. It acknowledges the concerns around the potential toxicity of nanoparticles to the host; few chapters will discuss the biodistribution of these nanoparticles when mucosal routes of administration are employed. Further, the interaction of nanoparticles with the host’s immune cells is discussed. Moreover,it reviews the regulatory aspects of nanotechnology in product development, especially when delivered by the mucosal route of administration. Lastly, discusses the challenges and opportunities to manufacture nanoparticles on an industrial scale. This book will be the first of its kind to focus on the design, development and delivery of nanoparticles when administered by different mucosal routes.

ISBN: 9783030359102

Standard No.: 10.1007/978-3-030-35910-2doiSubjects--Topical Terms:

768561
Pharmaceutical Sciences/Technology.

LC Class. No.: RS380

Dewey Class. No.: 615.19

Mucosal Delivery of Drugs and Biologics in Nanoparticles
LDR:03572nam a22004215i 4500 001 1023688
003 DE-He213
005 20200630050024.0
007 cr nn 008mamaa
008 210318s2020 gw | s |||| 0|eng d
020 $a 9783030359102 $9 978-3-030-35910-2
024 7 $a 10.1007/978-3-030-35910-2 $2 doi
035 $a 978-3-030-35910-2
050 4 $a RS380
050 4 $a RS190-210
072 7 $a TDCW $2 bicssc
072 7 $a MED072000 $2 bisacsh
072 7 $a TDC $2 thema
082 0 4 $a 615.19 $2 23
245 1 0 $a Mucosal Delivery of Drugs and Biologics in Nanoparticles $h [electronic resource] / $c edited by Pavan Muttil, Nitesh K. Kunda.
250 $a 1st ed. 2020.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a VIII, 277 p. 52 illus., 42 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a AAPS Advances in the Pharmaceutical Sciences Series, $x 2210-7371 ; $v 41
505 0 $a Section I Background -- Introduction to Nanomedicine -- Characterization of Nanoparticles -- Section II Drugs and Biologics Encapsulated in Nanoparticles -- Routes of Delivery -- Small molecule Delivery -- Peptide and Protein Delivery -- Gene Delivery (siRNA/CRISPR) -- Phage Therapy -- Section III Diseases -- Non-infectious Diseases -- Infectious Diseases -- Cancer -- Section IV Host Interactions with Nanoparticles -- Interaction of Nanoparticles with Epithelial and Immune Cells -- Toxicity of Nanoparticles to the Host -- Nanoparticle Pharmacokinetics and Pharmacodynamics -- Section V MIscellanous -- Nanoparticles as Theranostics -- Regulatory Perspectives -- Manufacturing Scale-up of Nanoparticles.
520 $a This book focuses on the application of nanotechnology to deliver drugs and biological agents by the mucosal routes of administration i.e. nasal, pulmonary, buccal, and oral routes.It provides an overview of nanotechnology in drug delivery with a description of different types of nanoparticles, methods of preparation and characterization, and functionalization for site-specific drug delivery. Mucosal Delivery of Drugs and Biologics in Nanoparticles emphasize the use of nanoparticles in treating various cancers and infectious diseases. It broadens the use of nanoparticles by including biologics, including vaccines and immunotherapies, apart from drugs. It acknowledges the concerns around the potential toxicity of nanoparticles to the host; few chapters will discuss the biodistribution of these nanoparticles when mucosal routes of administration are employed. Further, the interaction of nanoparticles with the host’s immune cells is discussed. Moreover,it reviews the regulatory aspects of nanotechnology in product development, especially when delivered by the mucosal route of administration. Lastly, discusses the challenges and opportunities to manufacture nanoparticles on an industrial scale. This book will be the first of its kind to focus on the design, development and delivery of nanoparticles when administered by different mucosal routes.
650 1 4 $a Pharmaceutical Sciences/Technology. $3 768561
650 0 $a Pharmaceutical technology. $3 557391
700 1 $a Kunda, Nitesh K. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1319689
700 1 $a Muttil, Pavan. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1319688
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030359096
776 0 8 $i Printed edition: $z 9783030359119
776 0 8 $i Printed edition: $z 9783030359126
830 0 $a AAPS Advances in the Pharmaceutical Sciences Series, $x 2210-7371 ; $v 20 $3 1255084
856 4 0 $u https://doi.org/10.1007/978-3-030-35910-2
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)